There are over 1,600 human clinical trials on probiotics listed in ClinicalTrials.gov and the WHO’s trial database, according to a new analysis that seeks to address the misconception that there is no human data around probiotics.
In light of the ongoing uncertainty around the COVID-19 public health crisis, the IPA World Congress + Probiota Americas 2020 has been canceled, but will return June 16-18, 2021 in Washington, D.C.
Athletes have greater gut diversity and more functional pathways within their microbiota than do their more sedentary peers. Why these facts are true is less clear, wrote the authors of a new comprehensive review.
In light of the ongoing novel Coronavirus (COVID19) public health emergency, IPA World Congress + Probiota Americas has been postponed until November 16-18, 2020 at the Crystal Gateway Marriott Hotel, Washington DC.
Delegate registration is open for the IPA World Congress + Probiota Americas in Washington DC, with speakers already confirmed covering topics including postbiotics, the changing retail landscape, microbes and the mitochondria, and fermented foods.
Calling all Probiotics, Prebiotics, and Microbiome start-ups!
NutraIngredients-USA is on the hunt for entrepreneurial consumer-facing, science- or technology-based start-ups to join our Probiota Pioneers session and present their company in Washington, DC.
Are you researching the latest state-of-the-art developments related to prebiotic, probiotic and microbiome science relevant to human health, well-being, consumers and industry? If so, we would like to hear from you!
This year we brought the IPA World Congress + Probiota Americas to Vancouver, where attendees explored the role of the microbiome in the US military, communicating science to consumers, and more. Here are some highlights:
A recent paper by the USP Expert Panel on probiotics has attracted some good attention, and that will hopefully translate into more stakeholders looking to get third-part quality certifications for their products, says USP’s Dr Kit Goldman.
Working with the Bill & Melinda Gates Foundation, DuPont is providing a “unique” probiotic strain to help treat sepsis in infants in Bangladesh, but the strain may also have commercial applications closer to home.
If a probiotic product is not averaging at least a 4.2 score in online consumer reviews, it could be headed for trouble from a sales standpoint, according to a recent study.
Euromonitor has seen a definite softening of the market for probiotic supplements, according to data presented at the recent Probiota Americas 2019 meeting.
In an age of information overload, how can scientists and researchers in the nutrition space make sure they’re communicating scientific findings and messages effectively to the public?
